TherapeuticsMD to ramp up birth control ring supply, shares jump

TherapeuticsMD

20/05/2022 17:29

** Shares of women-focused therapy maker  TXMD.O  jump 11.6%
to $2.54 - set for biggest intraday pct gain since mid-March
    ** Stock set to snap three straight sessions of losses, but
tracking ninth consecutive week of declines
    ** TXMD says the U.S. FDA approved marketing application for
its birth control ring Annovera which included some minor
changes related to manufacturing  urn:newsml:reuters.com:*:nBw9hYdJSa
    ** Annovera was approved by the FDA in August 2018
    ** TXMD says new approval allows for scaling up of
production; expects to make about 7,000 additional rings
available to customers in Q2 and Q3
    ** This year, stock plunged 87.2% up to the last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))